Glenn Turner, D.M.D., M.S.D., Director of the Maxillofacial Prosthetics Service and associate professor in the Department of Prosthodontics at the University of Florida College of Dentistry, is currently serving as president of the American Academy of Maxillofacial Prosthetics and will preside over the AAMP’s 57th annual meeting on San Diego, Ca., from October 31 through November 3.
Turner earned his bachelor’s degree from Auburn University in 1966 and completed dental school at the University of Alabama in 1970. After eight years as a general dentist, he comepleted a three-year residency at the University of Alabama with a specialty of Maxillofacial Prosthetics; he also earned his master’s degree in Dentistry.
Turner taught Prosthodontics at the University of Louisville, Ky., where he established a new postgraduate program as Director of Advanced Education in Prosthodontics. He joined UF in 1984 and since then has been Director of Maxillofacial Prosthetics at the College of Dentistry. From 2003 to 2005, he served as the Director of Advanced Education in Prosthodontics.
He is also on staff at Shands at UF and serves as a consultant for the Malcom Randall V.A. Medical Center. He is a member of the American Dental Association, American College of Prosthodontics, the American College of Dentistry and the International College of Dentistry. He served as president of the Florida Prosthodontic Association in 1991 and 2007.
Maxillofacial Prosthetics is the art and science of reconstructing head and neck defects with artificial material. The head and neck defects are caused by cancer surgery, traumatic injuries like automobile accidents, or congenital defects like cleft lip/cleft palate.
The American Academy of Maxillofacial Prosthetics (AAMP) has approximately 300 members nationwide and is dedicated to the study and practice of methods used to habilitate esthetics and function of patients with acquired, congenital and developmental defects of the head and neck; and of methods used to maintain the oral health of patients exposed to cancer-cidal doses of radiation or cytotoxic drugs. For more information, visit: www.maxillofacialprosth.org